Properties (34)
Predicate | Object |
---|---|
gptkbp:instanceOf |
patent
|
gptkbp:abstract |
A method for producing a recombinant protein.
|
gptkbp:applicationNumber |
10/775,123
|
gptkbp:assignee |
gptkb:XYZ_Corporation
|
gptkbp:citedBy |
gptkb:US_7,123,456_B2
|
gptkbp:claims |
20
|
gptkbp:description |
This patent describes a novel method for protein expression.
|
gptkbp:examiner |
Jane_Smith
|
gptkbp:expirationDate |
2024-01-30
|
gptkbp:fieldOfInvention |
biotechnology
|
gptkbp:filingDate |
2004-01-30
|
gptkbp:firstClaim |
The method of claim 1, wherein the process is scalable.
The method of claim 1, wherein the yield is increased. A method for producing a protein in a host cell. The method of claim 1, wherein the protein is a therapeutic protein. The method of claim 1, wherein the protein is produced in a fermenter. The method of claim 1, wherein the protein is purified. The method of claim 1, wherein the host cell is a bacterial cell. |
https://www.w3.org/2000/01/rdf-schema#label |
US 6,789,472 C11
|
gptkbp:internationalClassification |
C12N_15/00
|
gptkbp:inventor |
gptkb:John_Doe
|
gptkbp:issueDate |
2004-09-14
|
gptkbp:issuedBy |
gptkb:United_States_Patent_and_Trademark_Office
|
gptkbp:legalStatus |
granted
|
gptkbp:maintenanceFee |
paid
|
gptkbp:ninthClaim |
The method of claim 1, wherein the protein is a monoclonal antibody.
The method of claim 1, wherein the protein is a vaccine. The method of claim 1, wherein the host cell is modified. |
gptkbp:patentFamily |
US,_EP,_JP
|
gptkbp:patentType |
utility
|
gptkbp:priorityDate |
2003-01-30
|
gptkbp:relatedTo |
gptkb:US_6,123,456_A1
|
gptkbp:status |
active
|
gptkbp:technicalField |
genetic engineering
|